Denver, CO, March 20, 2018 (GLOBE NEWSWIRE) -- Denver, CO, March 20, 2018 - Medicine Man Technologies Inc. (OTC:MDCL) ("Medicine Man" or "Company"), one of the United States' leading cannabis branding and consulting companies, today announced that plans to report its financial results for the year ended December 31, 2017 on Tuesday, March 27, 2018 after market-close.
Medicine Man’s management, led by Brett Roper, co-Founder and Chief Executive Officer, will hold a conference call to review the results at 11:00 AM ET (9:00 AM MT) on Wednesday, March 28, 2018.
Mr. Roper will be answering shareholder questions at the end of the call. Should you have questions prior to the conference call, please send an email to MDCL@kcsa.com with “Medicine Man Question” in the subject line. Mr. Roper will answer as many questions as time will allow.
The dial-in information for the conference call is as follows:
Program Title: Medicine Man Technologies Full-Year 2017 Earnings Call
Canada & U.S.: (877) 407-9716
International: (201) 493-6779
Participants must request the Medicine Man Technologies Call.
A live audio webcast can be found at http://public.viavid.com/index.php?id=128832, and will be available on Medicine Man’s website at www.medicinemantechnologies.com, where it will be archived.
An audio replay of the conference call will be available through midnight April 11, 2018 by dialing +1 (844) 512-2921 from the U.S. or Canada, or +1 (412)-317-6671 from international locations, Conference ID: 13677785.
To be added to the Medicine Man email distribution list, please email, MDCL@kcsa.com with MDCL in the subject line.
About Medicine Man Technologies, Inc.
Established in March 2014, the Company secured its first client/licensee in April 2014. To date, the Company has provided guidance for several clients that have successfully secured licenses to operate cannabis businesses within their state. The Company currently has active clients in California, Iowa, Oregon, Colorado, Nevada, Illinois, Michigan, Arkansas, Pennsylvania, Florida, Ohio, Maryland, Massachusetts, Puerto Rico, Canada, Australia, Germany, and South Africa. We continue to focus on working with clients to 1) utilize its experience, technology, and training to help secure a license in states with newly emerging regulations, 2) deploy the Company's highly effective variable capacity constant harvest cultivation practices through its deployment of Cultivation MAX, and eliminate the liability of single grower dependence, 3) avoid the costly mistakes generally made in start-up, 4) stay engaged with an ever expanding team of licensees and partners, all focused on quality and safety that will "share" the ever-improving experience and knowledge of the network, and 5) continuing the expansion of our Brands Warehouse concept through entry into industry based cooperative agreements and pursuing other acquisitions as they prove suitable to our overall business development strategy.
Safe Harbor Statement
This press release may contain forward looking statements which are based on current expectations, forecasts, and assumptions that involve risks and uncertainties that could cause actual outcomes and results to differ materially from those anticipated or expected, including statements related to the amount and timing of expected revenues and any payment of dividends on our common and preferred stock, statements related to our financial performance, expected income, distributions, and future growth for upcoming quarterly and annual periods. These risks and uncertainties are further defined in filings and reports by the Company with the U.S. Securities and Exchange Commission (SEC). Actual results and the timing of certain events could differ materially from those projected in or contemplated by the forward-looking statements due to a number of factors detailed from time to time in our filings with the Securities and Exchange Commission. Among other matters, the Medicine Man Technologies may not be able to sustain growth or achieve profitability based upon many factors including, but not limited to, general stock market conditions. Reference is hereby made to cautionary statements set forth in the Company's most recent SEC filings. We have incurred and will continue to incur significant expenses in our expansion of our existing and new service lines, noting there is no assurance that we will generate enough revenues to offset those costs in both the near and long term. Additional service offerings may expose us to additional legal and regulatory costs and unknown exposure(s) based upon the various geopolitical locations where we will be providing services, the impact of which cannot be predicted at this time.